公开(公告)号：US20190194313A1

公开(公告)日：2019-06-27

申请号：US16325528

申请日：2017-08-03

Applicant: JOINT STOCK COMPANY "BIOCAD"

Inventor： Stanislav Rudolfovich EVDOKIMOV ,  Andrei Borisovich ULITIN ,  Valery Vladimirovich SOLOVYEV ,  Aleksei Aleksandrovich ALEKSANDROV ,  Yulia Sergeevna CHERNYKH ,  Timofey Aleksandrovich NEMANKIN ,  Anna Konstantinovna VLADIMIROVA ,  Oleg Igorevich SMOTROV ,  Tatiana Veniaminovna CHERNOVSKAYA ,  Aleksandr Aleksandrovich MOSHCHENKO ,  Viktoriia Evgenevna NALOBINA ,  Roman Alekseevich IVANOV ,  Dmitry Valentinovich MOROZOV

IPC: C07K16/24 ,  C12N15/63 ,  A61P37/06 ,  A61K9/00 ,  A61K9/19 ,  A61P37/08 ,  C07K16/06

CPC classification number: C07K16/248 ,  A61K9/0073 ,  A61K9/19 ,  A61K39/395 ,  A61P37/00 ,  A61P37/06 ,  A61P37/08 ,  C07K16/065 ,  C07K16/18 ,  C07K16/24 ,  C12N15/00 ,  C12N15/63

Abstract: The invention relates to medicine. The problem addressed by the present invention consists in creating alternative antibodies or fragments thereof which are capable of specifically binding to a human receptor of interleukin-6 and which would be useful as drugs for treating or diagnosing diseases, or for relieving symptoms, mediated by interleukin-6.